| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ... Nature genetics 41 (10), 1088, 2009 | 2852* | 2009 |
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ... Nature genetics 43 (5), 429, 2011 | 1427 | 2011 |
| The HITRAN database: 1986 edition LS Rothman, RR Gamache, A Goldman, LR Brown, RA Toth, HM Pickett, ... Applied optics 26 (19), 4058-4097, 1987 | 1239 | 1987 |
| Late-life depression, mild cognitive impairment, and dementia: possible continuum? F Panza, V Frisardi, C Capurso, A D'Introno, AM Colacicco, BP Imbimbo, ... The American Journal of Geriatric Psychiatry 18 (2), 98-116, 2010 | 515 | 2010 |
| APOE and Alzheimer disease: a major gene with semi-dominant inheritance E Genin, D Hannequin, D Wallon, K Sleegers, M Hiltunen, O Combarros, ... Molecular psychiatry 16 (9), 903, 2011 | 391 | 2011 |
| Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients A Pilotto, L Ferrucci, M Franceschi, LP D'Ambrosio, C Scarcelli, ... Rejuvenation research 11 (1), 151-161, 2008 | 295 | 2008 |
| Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease V Frisardi, V Solfrizzi, D Seripa, C Capurso, A Santamato, D Sancarlo, ... Ageing research reviews 9 (4), 399-417, 2010 | 274 | 2010 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373, 2017 | 265 | 2017 |
| European Alzheimer’s Disease Initiative Investigators. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease JC Lambert, S Heath, G Even, D Campion, K Sleegers, M Hiltunen, ... Nat Genet 41 (10), 1094-1099, 2009 | 259 | 2009 |
| Diet and Alzheimer’s disease risk factors or prevention: the current evidence V Solfrizzi, F Panza, V Frisardi, D Seripa, G Logroscino, BP Imbimbo, ... Expert review of neurotherapeutics 11 (5), 677-708, 2011 | 239 | 2011 |
| Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit M Franceschi, C Scarcelli, V Niro, D Seripa, AM Pazienza, G Pepe, ... Drug safety 31 (6), 545-556, 2008 | 206 | 2008 |
| Genetic susceptibility to nonsteroidal anti-inflammatory drug–related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms A Pilotto, D Seripa, M Franceschi, C Scarcelli, D Colaizzo, E Grandone, ... Gastroenterology 133 (2), 465-471, 2007 | 185 | 2007 |
| Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes A Sarkozy, E Conti, D Seripa, MC Digilio, N Grifone, C Tandoi, VM Fazio, ... Journal of medical genetics 40 (9), 704-708, 2003 | 154 | 2003 |
| Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors P Parrella, ML Poeta, AP Gallo, M Prencipe, M Scintu, A Apicella, ... Clinical Cancer Research 10 (16), 5349-5354, 2004 | 150 | 2004 |
| Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. S Gessani, U Testa, B Varano, P Di Marzio, P Borghi, L Conti, T Barberi, ... The Journal of Immunology 151 (7), 3758-3766, 1993 | 149 | 1993 |
| Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms F Panza, V Frisardi, C Capurso, BP Imbimbo, G Vendemiale, A Santamato, ... Journal of Alzheimer's disease 21 (3), 691-724, 2010 | 143 | 2010 |
| Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms V Frisardi, F Panza, D Seripa, BP Imbimbo, G Vendemiale, A Pilotto, ... Journal of Alzheimer's Disease 22 (3), 715-740, 2010 | 142 | 2010 |
| Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies F Panza, V Frisardi, V Solfrizzi, BP Imbimbo, G Logroscino, A Santamato, ... Immunotherapy 4 (2), 213-238, 2012 | 133 | 2012 |
| Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian case-control study M Margaglione, D Seripa, C Gravina, E Grandone, G Vecchione, ... Stroke 29 (2), 399-403, 1998 | 131 | 1998 |
| Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease BP Imbimbo, S Ottonello, V Frisardi, V Solfrizzi, A Greco, D Seripa, ... Expert review of clinical immunology 8 (2), 135-149, 2012 | 128 | 2012 |
